Columbia Laboratories's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Columbia Laboratories (CBRX)

Q2 2012 Earnings Call

August 8, 2012 11:00 am ET


Seth Lewis – The Trout Group, Columbia’s Investor Relations

Lawrence A. Gyenes – Senior Vice President, Chief Financial Officer & Treasurer

Frank C. Condella, Jr. – President & Chief Executive Officer


Raymond Myers – The Benchmark Co. LLC

Walter Schnecker – MAZ Partners

Harry Rosengart – HK & Associates

Raymond Myers – The Benchmark Co. LLC

James Dowling – Jefferies Capital Partners

Ralph Labriola – Stifel, Nicolaus & Co., Inc.

Christopher Castroviejo – Directional Research & Trading, Inc.



Good day, ladies and gentlemen. Welcome to Columbia Laboratories Second Quarter 2012 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session with instructions following at that time. (Operator Instructions) As a reminder, this conference call is being recorded.

Now, I’ll turn the conference over to Seth Lewis from the Trout Group. Please begin.

Seth Lewis

Thank you, operator, and thank you for joining us this morning for Columbia Laboratories second quarter 2012 financials results conference call. I am Seth Lewis of The Trout Group, Columbia’s Investor Relations firm, and with me this morning are Frank Condella, President and CEO, and Larry Gyenes, Senior Vice President, CFO and Treasurer of Columbia.

If you have not already received it, you can access the press release Columbia issued this morning at under the Investor’s tab, and you can also access the live webcast of this call from there.

During the course of this call, management will make projections and other forward-looking remarks regarding the future events and the company’s future performance. These forward-looking statements reflect Columbia’s perspective on current trends and information, and can be identified by such words as “expect,” “plan,” “will,” “may,” “anticipate,” “believe,” “could,” “should,” “intend,” “estimate,” “project,” and other words of similar meaning.

If you liked this article you might like

Biotech Stocks Triggering Breakout Trades: Columbia Labs

Healthcare Sector: High Quality Stocks At A Great Value

A Classic Biotech Long Shot

Columbia Stock Gaps Down On Today's Open (CBRX)